The small cap stocks had a good November with the Russell 2000 index this week hitting a new 52-week peak — higher than the ...

Finding the right treatment for erectile dysfunction (ED) can feel overwhelming with so many options out there! Rugiet, ...

On Wednesday, Hims & Hers Health Inc (HIMS) stock saw a decline, ending the day at $30.34 which represents a decrease of $-0.34 or -1.11% from the prior close of $30.68. The stock opened at $31.49 and ...

The bitter irony is that Republican policies in states with high obesity rates only exacerbate the gaps in health outcomes.

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions ...

Hims & Hers (HIMS) is up 14.0%, or $4.29 to $34.97.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium ...

(Goldman, 11/27) Bloomberg: Hims & Hers Shares Rally As FDA Pick Marty Makary Seen As Major Ally Hims & Hers Health Inc. shares surged 24% to close at fresh record after Hunterbrook Media said the ...

Nutrafol is a leader in supplement-based hair loss treatments, offering a natural way to support healthy hair growth. Their ...

Shares of Hims & Hers were on fire Monday because the FDA's new leader seems to be a fan of the company's business model.

3. Shares of virtual care company Hims & Hers spiked after the news that a telehealth ally could be running the FDA, Bloomberg reported Nov. 25. 4. Sesame provides compounded versions of the popular ...

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) has received a consensus rating of “Hold” from the sixteen analysts ...

Hims & Hers Health Inc. shares surged 24% to close at fresh record after Hunterbrook Media said the company is poised to be a ...